Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines, human experimentation, and ethics in evolutionary perspective

M R Hilleman1

  • 1Merck Institute for Therapeutic Research, Merck Research Laboratories, West Point, PA 19486, USA.

Developments in Biological Standardization
|December 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum.

Federation proceedings·2010
Same author

Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction.

Journal of immunology (Baltimore, Md. : 1950)·2010
Same author

Studies on lymphogranuloma venereum complement-fixing antigens; enhancement by phenol or boiling.

Journal of immunology (Baltimore, Md. : 1950)·2010
Same author

Studies on lymphogranuloma venereum complement-fixing antigens; fractionation with organic solvents of antigens of the psittacosis lymphogranuloma venereum group.

Journal of bacteriology·2010
Same author

On use of urea- and phenol-treated skin test antigens for diagnosis of lymphogranuloma venereum.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010
Same author

Double-stranded polynucleotides as interferon inducers.

The Journal of general physiology·2009

Ensuring safe and ethical clinical testing of biological products, especially vaccines, requires adherence to principles like informed consent and equitable distribution. Advances in technology and regulation enhance product quality and participant safety.

Area of Science:

  • Biomedical Science
  • Regulatory Science
  • Bioethics

Background:

  • Clinical testing of unlicensed biological products involves complex ethical and technological considerations.
  • Ensuring the highest quality, content, and safety of materials for human testing is paramount.
  • Vaccine testing necessitates strict adherence to the ethical principles of autonomy, beneficence, and justice.

Observation:

  • Ethical and technical factors are primary drivers for regulation by National Control Authorities.
  • Regulation is supported by guidelines from major National Control Authorities, the European Community, and the World Health Organization.
  • Well-trained regulatory staff and ongoing research are crucial for effective regulation.

Findings:

  • Increasing technical sophistication has mitigated past challenges in product development and testing.
Keywords:
Biomedical and Behavioral Research

Related Experiment Videos

  • Future vaccine development is expected to leverage established technologies, with new technologies adopted cautiously.
  • Adherence to ethical principles ensures the integrity and safety of clinical trials.

    • Implications:

    • Robust regulatory frameworks are essential for the safe and ethical advancement of biological product development.
    • Continued research and training for regulatory bodies will foster innovation while maintaining safety standards.
    • The careful integration of new technologies will shape the future of vaccine development and clinical testing.